Advertisement
UK markets close in 3 hours 49 minutes
  • FTSE 100

    8,119.29
    +40.43 (+0.50%)
     
  • FTSE 250

    19,814.26
    +212.28 (+1.08%)
     
  • AIM

    755.41
    +2.29 (+0.30%)
     
  • GBP/EUR

    1.1670
    +0.0013 (+0.11%)
     
  • GBP/USD

    1.2517
    +0.0006 (+0.05%)
     
  • Bitcoin GBP

    51,286.07
    +321.32 (+0.63%)
     
  • CMC Crypto 200

    1,383.71
    -12.82 (-0.92%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    84.17
    +0.60 (+0.72%)
     
  • GOLD FUTURES

    2,358.80
    +16.30 (+0.70%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,058.71
    +141.43 (+0.79%)
     
  • CAC 40

    8,045.71
    +29.06 (+0.36%)
     

BUZZ-Standard Life Aberdeen shares lose post-Phoenix deal lustre

** Shares (Berlin: DI6.BE - news) in Standard Life Aberdeen down 2.7 pct in late Friday trading after earlier being up more than 4 percent as market digests details of insurance unit sale to Phoenix.

** Analysts at UBS (LSE: 0QNR.L - news) , KBW among those to say the 3.24 bln stg cash-and-shares deal undervalues the unit.

** UBS analysts say in a note to clients that the deal lags their valuation of 3.4 bln stg and is "dilutive".

** UBS say the deal means the loss of "stable and significant earnings" at a time when SLA is suffering fund outflows. Rates the stock 'neutral' with 410 pence price target.

ADVERTISEMENT

** KBW analysts says similar deals would normally carry a premium, but this one looks to be at a discount. Rates stock as "market perform", with 376 pence price target.

** KBW says loss of earnings from unit calls dividend sustainability into question.